OncLive | Bringing the Global Oncology Community Together

Panagiotis A. Konstantinopoulos, MD, discusses the status of immunotherapy in ovarian cancer and focuses on numerous combinations under investigation. Read More >>

TNBC Pipeline Bursting With Effective Agents

Lead Investigator Says Tisagenlecleucel Has Changed Natural History of DLBCL

FDA Approves 23andMe Consumer Test for Hereditary CRC Syndrome

Recent Progress in Squamous NSCLC and SCLC Moves Needle Forward

Bekaii-Saab Brings Insight to Precision Medicine in GI Cancers

View More Stories >>

View Conference Coverage

2019 Transplantation and Cellular Therapy Meetings

2019 Winter Lung Cancer Conference

2019 SGO Winter Meeting

2019 Gastrointestinal Cancers Symposium

2018 State of the Science Summit on Advanced NSCLC

Dr. Horowitz on Frontline Strategies in Newly Diagnosed Ovarian Cancer

Dr. Kasi on the Rising Incidence of CRC

Dr. Steinberg on the Standard of Care in Non-Muscle Invasive Bladder Cancer

Dr. Clark Discusses Need for Biomarkers in RCC

Dr. Goetz on Survival Data With CDK4/6 Inhibitors in Breast Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Best Practices for Managing Patients on CDK4/6 Inhibitors

Multidisciplinary Care in Breast Cancer

Chemo + I-O in Frontline mNSCLC: PD-L1 TPS 1%-49%

Revolutionizing the Treatment of Ph+ ALL with TKIs

Effective Novel Agents in Upfront Treatment of ALL

How Age Affects Treatment Approaches in ALL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Selinexor Dose, Efficacy, and Adverse Effects

Emerging Therapies: SINE inhibitor & the STORM trial

Mantle Cell Lymphoma: Impact of Genetic Variants

Understanding the Heterogeneity of Mantle Cell Lymphoma

Progress in the Treatment of Multiple Myeloma

Glasdegib, Gilteritinib, and Quizartinib Against AML

Venetoclax for CLL After Progression on 1 Prior Therapy

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>